FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 48 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $108,000 | -20.6% | 19,500 | -33.5% | 0.00% | -33.3% |
| Q2 2017 | $136,000 | -73.4% | 29,340 | -71.6% | 0.01% | -76.9% |
| Q1 2017 | $511,000 | -96.6% | 103,290 | -92.4% | 0.03% | -96.6% |
| Q4 2016 | $14,995,000 | +19.9% | 1,350,847 | 0.0% | 0.77% | +11.8% |
| Q3 2016 | $12,509,000 | +45.8% | 1,350,847 | 0.0% | 0.69% | +41.9% |
| Q2 2016 | $8,578,000 | -2.6% | 1,350,847 | 0.0% | 0.48% | -8.0% |
| Q1 2016 | $8,808,000 | -19.6% | 1,350,847 | 0.0% | 0.53% | -24.5% |
| Q4 2015 | $10,955,000 | +10.6% | 1,350,847 | 0.0% | 0.70% | -5.5% |
| Q3 2015 | $9,902,000 | -14.8% | 1,350,847 | +19.2% | 0.74% | -16.2% |
| Q2 2015 | $11,617,000 | +208.5% | 1,133,390 | +178.4% | 0.88% | +189.2% |
| Q1 2015 | $3,766,000 | – | 407,121 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |